← Open Payments lookup

JILL HIPPENMEYER: Open Payments

NPI 1598354847 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$585 in 32 payments from 14 companies in 2025. Trend: 2023 $1,034 · 2024 $1,013 · 2025 $585

Food & beverage: $585
CompanyPaymentsAmount
Lilly USA, LLC9$143
Novo Nordisk Inc6$108
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$57
ABBVIE INC.3$51
Boehringer Ingelheim Pharmaceuticals, Inc.2$31
PFIZER INC.1$30
Verona Pharma, Inc.1$27
Axsome Therapeutics, Inc.1$26
Phathom Pharmaceuticals, Inc.1$25
AstraZeneca Pharmaceuticals LP1$21

Products named: MOUNJARO, JARDIANCE, CAPLYTA, Wegovy, Ozempic, VRAYLAR, Ohtuvayre, Auvelity.

Industry payments across IN — which companies pay providers there.